LIH cancer researcher awarded for best preclinical oral presentation
A strong representation of the NorLux Neuro-Oncology Laboratory from LIH’s Department of Oncology was present at the 14th annual meeting of the European Association of Neuro-Oncology (EANO).
Life Sciences and Euron PhD Days
This year’s PhD Days, held from 23rd to 25th September on the Belval Campus in Esch-sur-Alzette, combined a traditional Life Sciences PhD Day with the Euron conference.
Boosting research in digital epidemiology and e-health
In June 2019, Dr Guy Fagherazzi was appointed Research Leader of the “Digital Epidemiology and E-health hub”, a new strategic position at LIH’s Department of Population Health.
LIH and Tolerogenics collaborate on immune tolerance-promoting therapies
The Luxembourg-based biotech start-up Tolerogenics is developing novel immunotherapies based on the induction of immune tolerance.
Innovative approach that makes “cold” tumours “hot”
A recent news article in Nature Reviews Drug Discovery highlights innovative approaches aiming to improve the efficiency of cancer immunotherapy.
Luxembourg’s hepatitis C screening and care in drug users selected as example of best practice in Europe
The World Hepatitis Day on 28th July is an opportunity to raise awareness on the disease and on research conducted in this area.
Luxembourg Parkinson’s Study funded with an additional six million euros
The Luxembourg National Research Fund (FNR) has committed an additional six million euros to the National Centre for Excellence in Research on Parkinson’s Disease (NCER-PD), paving the way for the second phase of this collaborative research programme.
Bringing biomedical research closer to the patient: appointments to strategic positions
LIH is currently refining its research strategy to focus more on translational research, placing patients and the population at the centre of its activities.